<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>SyndicateMizzou Video Podcast</title>
    <link>http://www.syndicatemizzou.org</link>
    <pubDate>Fri, 09 Jan 2009 23:19:09 GMT</pubDate>
    <language>en-us</language>
    <ttl>40</ttl>
    <generator>Center for eResearch</generator>
    <description>Connecting you with the University of Missouri’s innovative research and creative activity</description>
    <image>
      <url>http://www.syndicatemizzou.org/images/logo.png</url>
      <title>SyndicateMizzou</title>
      <width>384</width>
      <height>80</height>
    </image>
    <item>
      <title>SyndicateMizzou Podcast: Ted  Tarkow - Synthesis of an Analog of the Novel Anti-neoplastic Agent Leinamycin</title>
      <link>http://syndicatemizzou.org/resources/urm2006/ipod/URM-Hicks.m4v</link>
      <category>Education</category>
      <guid>http://syndicatemizzou.org/resources/urm2006/ipod/URM-Hicks.m4v</guid>
      <description>####Andrea Hicks, Chemistry

####Kent Gates, Mentor

Leinamycin is a potent anti-tumor antibiotic that was isolated from a culture of _Streptomyces_ in 1989.  The unique compound features a 1,2-Dithiolan-3-one 1-oxide heterocycle which can cause DNA damage through multiple pathways.  Hydrolysis t ½ of previous leinamycin analogs containing only the 1,2-Dithiolan-3-one 1-oxide group was approximately two hours, as compared to twenty-seven hours for leinamycin.  The purpose of this project is to synthesize the leinamycin analog. This compound will be used to investigate the effect of a leinamycin-like vicinal amide group on the hydrolysis half-life of the 1,2-dithiolan-3-one-1-oxide.</description>
      <duration>3</duration>
      <pubDate>Mon, 13 Nov 2006 16:29:19 GMT</pubDate>
      <enclosure url="http://syndicatemizzou.org/resources/urm2006/ipod/URM-Hicks.m4v" type="video/quicktime"/>
    </item>
  </channel>
</rss>
